Our results presented that pretreated melanoma cells with AKT or STAT3 pathway-specific inhibitor could partially reverse TRIM14 induced tumor cell proliferation, clone formation capacity, invasion, epithelial-mesenchymal transition as well as melanin synthesis capacity. Here, TRIM14 is linked to melanoma.